Robert Bruce started to build up the position in Paratek Pharmaceuticals in Q2 2019 and continued to invest until Q1 2022. Since then they sold 1.56 Million shares. The investor completely sold their stake between Q1 2023 and Q3 2023.
Avg closing price
Price range
Sold -1.56 Million shares
Q3 2023
Avg closing price
$2.20
Price range
$2.18
-
$2.23
Sold 0.1% shares (-1.07 Thousand shares)
Q1 2023
Avg closing price
$1.98
Price range
$1.37
-
$2.54
Increased shares by 7.9% (+114 Thousand shares)
Q1 2022
Avg closing price
$3.76
Price range
$2.94
-
$4.77
Increased shares by 7.4% (+100 Thousand shares)
Q4 2021
Avg closing price
$4.74
Price range
$4.07
-
$5.30
Increased shares by 15.5% (+180 Thousand shares)
Q3 2021
Avg closing price
$5.51
Price range
$4.70
-
$7.24
Increased shares by 25.2% (+234 Thousand shares)
Q1 2021
Avg closing price
$7.20
Price range
$6.14
-
$8.31
Increased shares by 5.7% (+50 Thousand shares)
Q4 2020
Avg closing price
$5.88
Price range
$4.58
-
$7.14
Increased shares by 55.2% (+313 Thousand shares)
Q3 2020
Avg closing price
$4.95
Price range
$4.19
-
$6.69
Increased shares by 21.4% (+100 Thousand shares)
Q2 2020
Avg closing price
$4.44
Price range
$2.97
-
$5.22
Increased shares by 75.0% (+200 Thousand shares)
Q1 2020